FDA Food Chemicals Review Process Expands Transparency and AI Monitoring

The US Food and Drug Administration (FDA) has published an enhanced systematic process for the post-market assessment of chemicals in food, setting out how it will identify, prioritise and review food additives, colour additives, GRAS substances, food contact substances and contaminants already in the food supply. The May 2026 framework gives food, packaging, ingredients and retail stakeholders clearer insight into future FDA food chemicals review activity.

FDA food chemicals review adds structured post-market oversight

The revised process follows the FDA’s August 2024 discussion paper, a September 2024 public meeting and more than 70,000 public comments submitted before the docket closed on 21 January 2025. The agency says the process will cover signal detection, triage, prioritisation, scientific assessment, stakeholder engagement and risk management. It is intended to make post-market food chemical oversight more systematic and transparent.

AI signal detection and annual work plans

A central feature is WILEE, the Warp Intelligent Learning EnginE, an AI platform using machine learning to scan sources such as PubMed, international food safety organisations, trade groups, the press and the open web for emerging information on food chemicals. Signals may include new hazard data, changes in exposure, contamination above action levels, adverse reactions or shifts in how chemicals are used in food, packaging or processing. The FDA will also use traditional sources, including regulatory activity, adverse event reports, FDA submissions, news reports and trade press. Public nominations of food chemicals for assessment are planned, with details to follow.

Public consultation and risk management

The FDA will publish a yearly post-market work plan listing chemicals selected for assessment. Inclusion on the work plan will not mean a chemical is unsafe, only that the FDA is reviewing whether new information warrants further action. For most assessments, the FDA intends to issue 60-day data calls, publish preliminary scientific assessments for comment and release final assessments. In some cases, preliminary assessments may also undergo peer review. Possible risk management measures include amending or revoking authorisations, voluntary phase-outs, recalls, import refusals, contaminant action levels, specified limits and alerts.

Implications for food and chemicals stakeholders

Manufacturers, importers, ingredient suppliers, packaging firms, retailers and laboratories should expect greater scrutiny of data on use levels, dietary exposure, toxicology, migration from packaging, contaminant levels and mitigation measures. The FDA notes that industry data can be important because conservative exposure assumptions may overestimate dietary exposure and lead to unnecessary risk management action.

Summary

The FDA food chemicals review process marks a more transparent and proactive approach to post-market oversight. By combining AI-supported monitoring, annual work plans and public consultation, the agency aims to identify potential risks earlier while giving industry clearer routes to provide data and prepare for regulatory action.

FAQs

What is the FDA food chemicals review process?

The FDA food chemicals review process is a system for assessing substances already present in food, including additives, colour additives, GRAS substances, food contact substances and contaminants. It helps the FDA decide whether new scientific evidence or exposure data requires updated safety conclusions or risk management action.

Does FDA review mean a food chemical is unsafe?

No. The FDA states that inclusion in a work plan or review list does not mean a chemical is unsafe. It means the agency is assessing whether new information requires further investigation, a change in regulatory conclusions or additional action to protect the food supply.